Polaris AI Pharma Corp. (KOSDAQ:041910)
South Korea · Delayed Price · Currency is KRW 5,330.00
+180.00 (3.50%)
At close: Aug 24, 2026
Polaris AI Pharma Market Cap
Polaris AI Pharma has a market cap or net worth of 68.41 billion as of August 21, 2026. Its market cap has decreased by -16.26% in one year.
Market Cap
68.41B
Enterprise Value
n/a
Revenue
63.94B
Ranking
n/a
PE Ratio
60.79
Stock Price
5,330.00
ChartMarket Cap Chart
Since May 17, 2004, Polaris AI Pharma's market cap has increased from 10.75B to 68.41B, an increase of 536.37%. That is a compound annual growth rate of 8.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 68.41B | -17.34% |
| Dec 30, 2025 | 82.76B | 16.23% |
| Dec 30, 2024 | 71.20B | -11.66% |
| Dec 28, 2023 | 80.59B | -2.68% |
| Dec 29, 2022 | 82.81B | -26.15% |
| Dec 30, 2021 | 112.13B | -24.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 85.75B |
| Sam-A Pharm. | 83.55B |
| KOREA PHARMA | 82.24B |
| Daehan Nupharm | 78.32B |
| Optipharm.CO.,LTD | 66.97B |
| Hwail Pharmaceutical | 66.84B |
| Sinsin Pharmaceutical | 66.30B |
| Sinil Pharmaceutical | 66.21B |